contact us


Ureteric strictures result from fibrosis in the wall of the ureter, resulting in narrowing of the utereric lumen which could in turn lead to significant morbidity and loss of a functioning kidney. Treatment (and prevention) involves placing a ureteric stent within the ureter for up to 6 weeks, which is then removed.

Current stents serve only as passive internal scaffolds and do not address any pathology e.g. fibrosis, infection, tumours. The team has developed a novel swellable hydrogel coating which can be applied to commercially available stents, which allows drug elution of mitomycin C (MMC) to prevent fibrosis.

Project Deliverables

A MMC-loaded stent coating which has been tested for the following: i) safety and feasibility of insertion/removal of the stent in a pig model, ii) quantification of the drug concentration of MMC delivered by the coated stent in ureteric tissue, and iii) efficacy of MMC in preventing stricture formation.

Principal Investigator: Dr CHONG Tsung Wen

Institution: Singapore General Hospital

NHIC Ref: NHIC-I2D-1506051



See all BIOPHARMA projects >

Automated Bio-Imaging Platform for Rheumatoid Arthritis

Ultrasound (US) allows precise disease characterisation in rheumatoid arthritis. Presently, the m...

Mobile Interactive Supervised Therapy

Medication adherence in tuberculosis treatment is critical for patient’s cure, infection control...

Development of highly conductive microneedle array for painless dental anaesthesia

Pain management during dental procedures is a cornerstone for successful everyday practice. Curre...

Novel inhibitors for Natural Killer/T-cell lymphoma (NKTCL)

The Natural Killer/T-cell lymphoma (NKTCL) is a subtype of Non-Hodgkin’s lymphoma (NHL) which is...

Assay for Early Detection of Flares in Patients with Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an autoimmune condition which affects multiple organ system...

Biomarker for Rapid Diagnosis and Prediction of Severity of Acute Pneumonia

According to the World Health Organization, lower respiratory tract infections are the leading ca...


Clinical Partners

nhg logonuhs logosinghealth


Academic Partners

lkc medicalnus faculty of dentistrynus sphnus somduke nus


Supporting Partners

bms ipodxdipinmrcSCRIseriSMARTEnterpriseSGCatalystSingaporeBioDesign